Skip to main content
SpringerLink
Log in

Emerging Transplant Infections

Clinical Challenges and Implications

  • Living reference work
  • © 2020

Overview

Editors:
  1. Michele I. Morris

    1. Miller School of Medicine, University of Miami, Miami, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Camille Nelson Kotton

    1. Massachusetts General Hospital, Harvard University, Boston, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Cameron Wolfe

    1. Duke University, Durham, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Peer reviewed, updateable resource
  • Includes detailed clinical guidelines often not covered other updateable resources
  • Written by experts in emerging transplant infections

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (69 entries)

  1. Acanthamoeba, Naegleria, and Balamuthia in Transplant Patients: An Emerging Threat

    • Yoram A. Puius, Margaret L. Aldrich, Jennifer R. Cope

  2. Altered Mental Status in the Solid Organ Transplant Recipient

    • Dilek Ince

  3. Antimicrobial Prophylaxis in the Age of Emerging Transplant Infections

    • Jonathan Hand

  4. Antimicrobial Stewardship for Transplant Candidates and Recipients

    • Catherine Liu, Erica J. Stohs

  5. Aspergillus in Solid Organ and Stem Cell Transplant Patients: Emerging Options for Diagnosis and Management

    • Armelle Pérez-Cortés Villalobos, Shahid Husain

  6. BK Polyomavirus After Solid Organ and Hematopoietic Cell Transplantation: One Virus – Three Diseases

    • Fabrice E. Graf, Hans H. Hirsch

  7. Burkholderia in Transplant: Important to Speciate and Important to Treat

    • Gregory Snell, Olivia Smibert, Elizabeth Tullis

  8. Candida Infections in Solid Organ Transplantation

    • Nicolas Barros, Michael K. Mansour

  9. Chagas Disease: Coming to a Transplanted Patient Near You

    • Lígia Camera Pierrotti, Karim Yaqub Ibrahim

  10. Challenges of Human Papillomavirus Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients

    • Cristina Brickman, Peter Chin-Hong

  11. Changing Definition of Immunosuppression: Targeted Therapies and Resulting Emerging Infections and Their Prevention

    • Nicolas J. Mueller

  12. Clostridioides Difficile: Where Should the Management Strategies in Transplant Vary?

    • Jennifer C. Pisano, Kathleen M. Mullane

  13. Coccidioidomycosis in Transplantation

    • Brandon T. Nokes, Janis E. Blair

  14. Common and Emerging Infections in Pediatric Transplant Recipients

    • Jennifer E. Schuster, Hilary Miller-Handley, Lara Danziger-Isakov

  15. Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients: Prevention, Diagnosis, and Treatment

    • Jose F. Camargo

  16. Cytomegalovirus in Solid Organ Transplant Recipients: Prevention, Diagnosis, and Treatment

    • Camille Nelson Kotton

  17. Diarrhea in Transplant: Diagnosis and Management

    • Diana F. Florescu, Andrea Zimmer

  18. Emerging Diagnostics for Transplant Infectious Diseases

    • Marwan M. Azar, David C. Gaston, Maricar F. Malinis

  19. Emerging Epidemics in Transplant: Histoplasmosis, Blastomycosis, and Paracoccidioidomycosis

    • Jeremy Nel, Anne Lachiewicz, David van Duin

  20. Emerging Management of Hepatitis C in Transplant

    • Lorena Puchades, Marina Berenguer
Back to top

Keywords

About this book

The field of transplant medicine has evolved significantly since the first kidney transplant was performed in 1954. Innovations in transplant immunosuppression have lowered the risk of organ rejection so that infectious complications are now the leading cause of hospitalization and mortality after solid organ transplant. Infection is also cited as the leading cause of non-relapse mortality after stem cell transplantation. As transplant centers have recognized the importance of transplant specific expertise in patient outcomes, the field of transplant infectious diseases has expanded into a recognized and highly valued subspecialty. International growth in solid organ and stem cell transplantation has outpaced access to such expertise, with some centers employing microbiology laboratory directors and transplant nephrologists as their lead infectious diseases consultants. This has been a particular challenge as the use of novel immunosuppressive regimens in new geographic and immigrant populations have fueled the emergence of new infection syndromes, with the initial presentation sometimes occurring in this most vulnerable patient population.

 This digital-first book is designed to meet the needs of practitioners engaged in transplant infectious disease practice who need more depth than they are able to find in UpToDate. It provides an overview of emerging infectious disease challenges with clinically relevant information regarding the epidemiology, diagnosis, management, and prevention of infections in solid organ and stem cell transplant recipients. Each chapter focuses on a clinical syndrome or pathogen with new or emerging implications for transplant patients.

 Given the rapidly evolving nature of emerging infections and topics in transplant infections, no resource has been published on these increasingly notorious issues; this this text is written by top, global experts who regularly update the material to ensure that readers will always have access to the most cutting edge material available.

The editorial team consists of three experienced leaders in the field, all of whom have a strong record of scholarship and publication, as well as an international reputation. All three have focused their academic careers on emerging infectious diseases in transplantation, including a current and a past president of various infectious diseases and transplantation societies.  The editors are also experienced reviewers and authors who have collaborated on multiple previous projects. All are committed to this project as a unique opportunity to make an important contribution to their field.

Editors and Affiliations

  • Miller School of Medicine, University of Miami, Miami, USA

    Michele I. Morris

  • Massachusetts General Hospital, Harvard University, Boston, USA

    Camille Nelson Kotton

  • Duke University, Durham, USA

    Cameron Wolfe

About the editors

Michele I. Morris, M.D., FACP, FIDSA, FAST
Professor of Clinical Medicine
Director, Immunocompromised Host Service
Division of Infectious Diseases
University of Miami Miller School of Medicine
1120 N.W. 14th St., Suite 842 (R-21)
Miami, FL 33136


Camille Nelson Kotton MD, FIDSA, FAST
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Massachusetts General Hospital
Harvard Medical School
55 Fruit Street, Cox 5
Boston, MA 02114 USA


Dr Cameron R.Wolfe MBBS(Hons), MPH, FIDSA
Associate Professor of Medicine
Transplant Infectious Disease
DUMC #102359, Rm 159,
Hanes House, Trent Drive
Durham, NC, 27710

 

Michele I. Morris, M.D., FACP, FIDSA, FAST is an Associate Professor of Clinical Medicine in the Division of Infectious Diseases at the University of Miami Miller School of Medicine in Miami, Florida. She isDirector of the Immunocompromised Host Section, providing consultation services to hematology/oncology patients and solid organ and stem cell transplant recipients at Jackson Memorial Hospital and Sylvester Cancer Center. She is currently President of the international Transplantation Society Transplant Infectious Diseases section. She has published over 50 papers and 5 book chapters. In addition to being an active academic clinician, she has been the principal investigator in over 25 clinical trials. Her clinical research focuses on the diagnosis and management of invasive fungal and mycobacterial infections and the prevention and treatment of transplant-related infectious diseases with a focus on tropical and transplant donor-derived infections.

 

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation